- NXGL Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1/A Filing
NEXGEL (NXGL) S-1/AIPO registration (amended)
Filed: 19 Apr 19, 5:28pm
Exhibit 99.4
CONSENT OF PROPOSED DIRECTOR
Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, the undersigned hereby consents to be named in this Registration Statement on Form S-1 (the “Registration Statement”) of AquaMed Technologies, Inc., and any amendments thereto, as a person who is about to become a director on the Board of Directors of AquaMed Technologies, Inc. in connection with the spin-off by Alliqua BioMedical, Inc. of AquaMed Technologies, Inc. and the subsequent merger of AQ TOP, LLC and TO Pharmaceuticals, LLC. The undersigned also consents to the filing of this consent as an exhibit to the Registration Statement.
/s/ Seth Yakatan | |
Seth Yakatan |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.